NCT06036589 is a NA clinical trial of CA and BAM8-22 in Itch, sponsored by Aalborg University.

Who is sponsoring NCT06036589?

NCT06036589 is sponsored by Aalborg University.

What drugs are being tested in NCT06036589?

Interventions in NCT06036589: CA and BAM8-22, Vehicle and BAM8-22 application, CA, vehicle.

Is NCT06036589 still recruiting?

NCT06036589 is currently completed. Last updated 14 September 2023.

Last reviewed 2023-09-14 · How we verify

NCT06036589

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Characterization of Bovine Adrenal Medulla as a Model of Non-histaminergic Itch

Completed NA Last updated 14 September 2023

What this trial tests

NA trial testing CA and BAM8-22 in Itch in 25 participants. Completed in 30 October 2022.

Timeline

10 March 2022

Primary endpoint
30 May 2022

30 October 2022

Quick facts

Lead sponsor	Aalborg University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	sequential
Masking	single
Primary purpose	basic science
Enrollment	25
Start date	10 March 2022
Primary completion	30 May 2022
Estimated completion	30 October 2022
Sites	1 location across Denmark

Drugs / interventions tested

CA and BAM8-22 — full drug profile →
Vehicle and BAM8-22 application — full drug profile →
CA — full drug profile →
vehicle

Conditions studied

Itch — all drugs for Itch →

Sponsor

Aalborg University

Who can join

Adults 18 to 60, any sex, with Itch. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

With this experiment, the experimenter wish evaluate the role of TRPA1 on non-histaminergic itch induced by BAM8-22

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Itch

Currently open trials in the same condition.

NCT07122973 — Topographical Distribution of Itch and Pain Receptors · NA · recruiting
NCT06997926 — Identification of the Mechanism of Non-histaminergic Itch Inducing Epigenetic Changes · NA · active not recruiting
NCT06503510 — Role of Interleukin-13 Pathways on Pain and Itch Sensitivity · NA · recruiting
NCT06503523 — The Effects of Performing a Motor Imagery Task on Cortical Excitability During Acute Experimental Muscle Pain and Acute · NA · recruiting

Other Aalborg University trials

Trials by the same sponsor.

NCT07580989 — Network Effects of Left M1 rTMS: A TMS-EEG Study · NA · recruiting
NCT07395882 — A New Model to Induce Itch and Inflammation · NA · not yet recruiting
NCT07395869 — Off-set Analgesia Induced by Cold Temperature · NA · not yet recruiting
NCT07266103 — Mechanistic Study of Personalized rTMS in Chronic Pain · NA · not yet recruiting
NCT07373392 — Effects of LP-LDL® on Lipid Metabolism, Glycemic Control, Inflammatory Markers, and Cognitive Function in Individuals Wi · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06036589 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aalborg University
Last refreshed: 14 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06036589.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing